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Abstract 
 
     Previous studies on the cytotoxicity of arachidonic acid (ARA) elucidated the 
involvement of oxidative stress and Ca2+. In the present study, the Zn2+-related cytotoxicity of 
ARA was studied by a flow cytometric technique with appropriate fluorescent probes in rat 
thymocytes. Addition of 10 µM ZnCl2 enhanced the increase in cell lethality induced by 10 µM 
ARA. The removal of Zn2+ by Zn2+ chelators attenuated the ARA-induced increase in cell 
lethality. Thus, Zn2+ is suggested to be involved in ARA cytotoxicity. ARA at 3–10 µM 
elevated intracellular Zn2+ level. The Zn2+ chelators attenuated the ARA-induced increase in 
intracellular Zn2+ level while ARA significantly increased intracellular Zn2+ level in the 
presence of 3 µM ZnCl2, suggesting the involvement of external Zn2+. Zn2+ reportedly exerts 
cytotoxic action under oxidative stress induced by hydrogen peroxide, via an excessive increase 
in intracellular Zn2+ levels. Since ARA induces oxidative stress, the simultaneous administration 
of zinc and ARA may be harmful. (155 words) 
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Introduction 
 
     Polyunsaturated fatty acids are essential fatty acids that humans cannot synthesize and 
have a variety of nutritional and biochemical properties (Benatti et al., 2004). Various studies 
have reported the anti-aging actions of polyunsaturated fatty acids (Cole et al., 2010; Janssen 
and Kiliaan, 2014). However, some omega-3 and 6 polyunsaturated fatty acids exert cytotoxic 
actions on leukemia cell lines, melanoma cell lines, and lymphocytes in vitro (Finstad et al., 
1998; Andrade et al., 2005; Otton and Curi, 2005). Such polyunsaturated fatty acids also kill rat 
thymic lymphocytes by inducing the release of Ca2+ from the endoplasmic reticulum, which 
causes the release of reactive oxygen species, that leads to cell death, from mitochondria 
(Prasad et al., 2010). In addition, cell death by polyunsaturated fatty acids is preceded by 
reduction of both plasma and mitochondrial membrane potential, and occurs via apoptosis of 
murine thymocytes (Åhs et al., 2011). Oxidative stress and/or excessive elevation in 
intracellular Ca2+ level are involved in the cell death induced by polyunsaturated fatty acids. 
The relationship between polyunsaturated fatty acids and oxidative stress has been investigated 
in the studies of Pompéia et al. (2002, 2003). 
     In our previous study (Matsui et al., 2010), the application of ZnCl2 at low micromolar 
concentrations exerted cytotoxic action under oxidative stress induced by hydrogen peroxide, in 
rat thymic lymphocytes. Zn2+ is released from cellular thiols under oxidative stress conditions, 
which then convert thiols to disulfides (Maret, 1994; Jacob et al., 1998; Kinazaki et al., 2011). 
Thus, the buffering ability that maintains physiological intracellular Zn2+ levels appears to 
decrease in the presence of polyunsaturated fatty acids that induce oxidative stress. Therefore, 
the cytotoxicity of polyunsaturated fatty acids might be related to Zn2+ if polyunsaturated fatty 
acids induce oxidative stress. To test this hypothesis, the effect of arachidonic acid (ARA), one 
of polyunsaturated fatty acids, on rat thymic lymphocytes was examined using appropriate 
fluorescent probes for cell viability and intracellular Zn2+ levels, and a flow cytometer to 
measure fluorescence. And, the cytotoxic action of ARA was further studied. The usage of 
ARA and zinc as supplements is expected to expand because of their proposed beneficial effects 
in the elderly and infants. Therefore, it is important to further characterize the cytotoxicity of 
ARA to ensure their safe use. 
 
 
Methods and Materials 
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Cell preparation 
     This study was approved by the Committee for Animal Experiments of Tokushima 
University, Tokushima, Japan (No. 14124). Experimental methods were similar to those 
described in previous papers. The cell suspension was prepared as previously reported by 
Chikahisa et al. (1996) and Matsui et al. (2010). In brief, thymus glands dissected from 
ether-anesthetized rats were sliced under ice-cold conditions. The slices were triturated in 
Tyrode's solution to dissociate the thymocytes. The cell suspension was incubated at 36–37°C 
for 1 h before the experiment. It is noted that the cell suspension contained 216.9 ± 14.4 nM 
zinc derived from cell preparations (Sakanashi et al., 2009). 
Chemicals 
     ARA, docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and linoleic acid (LA) 
were purchased from Cayman Chemical (Ann Arbor, MI, USA) and Tokyo Chemical Industry 
Co., Ltd. (Tokyo, Japan). FluoZin-3-AM, 5-chloromethylfluorescein diacetate (5-CMF-DA), 
annexin V-FITC, and propidium iodide were obtained from Molecular Probes Inc., Invitrogen 
(Eugene, OR, USA). Other chemicals were obtained from Wako Pure Chemicals (Osaka, Japan). 
The chelators of Zn2+, diethylenetriamine-N,N,N',N",N"-pentaacetic acid (DTPA) and 
N,N,N',N'-Tetrakis(2-pyridylmethyl)ethylenediamine (TPEN), were purchased from Dojindo 
(Kumamoto, Japan). 
Fluorescence measurements of cellular parameters 
     Cell lethality was assessed using propidium iodide, the dye was added to the cell 
suspension at a final concentration of 5 µM. Exposure of phosphatidylserine on outer surface of 
cell membranes, a phenomenon during apoptosis, was detected using annexin V-FITC. 
FluoZin-3-AM (500 nM) was added to the cell suspension to assess the change in intracellular 
Zn2+ concentrations (Gee et al., 2002). FluoZin-3 fluorescence was measured from the cells that 
were not stained with propidium (living cells with intact membranes). The cellular content of 
nonprotein thiols was estimated with 5-CMF-DA. The correlation coefficient between the 
intensity of 5-CMF fluorescence monitored from rat thymocytes and the cellular content of 
glutathione was 0.965 (Chikahisa et al., 1996). Fluorescence intensity was measured and 
analyzed using a flow cytometer (CytoACE-150, JASCO, Tokyo, Japan). The excitation 
wavelength was 488 nm. Fluorescence of FITC, FluoZin-3, and 5-CMF was detected at 530 ± 
20 nm. Propidium fluorescence was detected at 600 ± 20 nm. 
Statistical analysis 
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     Statistical analyses were performed using an ANOVA with a post-doc Tukey's 
multivariate analysis. P-values of less than 0.05 were considered significant. The results 
(including columns and bars in figures) were expressed as the mean and standard deviation of 
the 4-42 samples.  
 
Results 
 
Changes in cell lethality by ARA, DHA, EPA, and LA 
     As shown in Fig. 1A, the incubation of rat thymocytes with 10 µM ARA for 1 h increased 
the population of cells exhibiting propidium fluorescence (the population of dead cells). The 
increase in cell lethality by 10 and 30 µM ARA was statistically significant. This was not the 
case for 3 µM ARA (Fig. 1B). DHA at a concentration of 30 µM, but not 10 µM, significantly 
increased the lethality (Fig. 1B). EPA and LA did not significantly affect the lethality at 
concentrations of up to 30 µM (Fig. 1B). 
    In the experiments described below, the concentration of ARA to decrease cell viability 
was selected to characterize the cytotoxic action. ARA at 10 µM started to decrease cell 
viability of rat thymocytes (Fig. 1).  The plasma concentration of arachidonic acid in human 
was reported to be 1143 ± 468 ng/mL (Shinde et al., 2012). Calculated molar concentration is 
3.7 ± 1.5 µM. Therefore, the test concentration of ARA (10 µM) is higher than plasma 
concentration of ARA in healthy human. 
(Figure 1 near here) 
ARA-induced increase in population of dead cells positive to annexin V 
     To see if the apoptotic process is involved in the cytotoxicity of ARA, the experiments 
were performed using annexin V-FITC. The treatment with 10 µM ARA for 1 h increased the 
population of dead cells positive to annexin V, one of markers for apoptosis, from 2.2 ± 0.2 % 
(mean ± SD of 4 samples) to 27.8 ± 1.5 %. Furthermore, the cell size, estimated from the 
change in forward scatter, of annexin V-positive dead cells was 97.0 ± 6.5 (mean ± SD in 
arbitrary unit of 4 samples) while it was 167.6 ± 1.0 in the case of intact living cells. There were 
no significant changes in the population of annexin V-positive living cells and annexin 
V-negative dead cells by the 1 h treatment with 10 µM ARA. The changes in some parameters 
suggest apoptotic events in the ARA-induced cytotoxicity. 
Zinc-induced increase in cytotoxicity of ARA 
     There was a possibility that the simultaneous application of micromolar ZnCl2 further 
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increased the cytotoxicity of ARA because ARA exhibited oxidative stress (Pompéia et al., 
2002, 2003) and ZnCl2 induced cell death under oxidative stress (Matsui et al., 2010). As shown 
in Fig. 2A, the simultaneous application of 3–10 µM ZnCl2 and 10 µM ARA further increased 
the population of cells exhibiting propidium fluorescence. The increase in cell lethality by the 
addition of ZnCl2 was statistically significant in the case of 10 µM ZnCl2. To deduce if Zn2+ is 
involved in the ARA-induced increase in cell lethality, the effects of Zn2+ chelators, DTPA and 
TPEN, were tested. Both Zn2+ chelators significantly reduced the ARA-induced increase in cell 
lethality (Fig. 2B).  
(Figure 2 near here) 
Effects of celecoxib and indomethacin on ARA-induced increase in cell lethality 
     ARA is metabolized to several types of bioactive substances such as prostaglandins by 
cyclooxygenases (Smith et al., 1996). To determine if the metabolites of ARA are involved in 
the induction of cell death, the effect of 10 µM ARA was examined in the presence of 
cyclooxygenase inhibitors such as indomethacin and celecoxib (Rao and Knaus, 2008). 
Respective cyclooxygenase inhibitors were applied to the cells just before the start of ARA 
application. As shown in Fig. 3, 1 µM indomethacin and 1 µM celecoxib partly, but 
significantly, attenuated the ARA-induced increase in cell lethality. 
(Figure 3 near here) 
Increase in intracellular Zn2+ levels by ARA 
     Incubation with 10 µM ARA for 1 h shifted the histogram of FluoZin-3 fluorescence of 
rat thymocytes to a direction of higher intensity (Fig. 4A), indicating the ARA-induced 
elevation of intracellular Zn2+ levels. The mean intensity of FluoZin-3 fluorescence in the 
presence of 10 µM ARA was 74.2 ± 8.8 (mean ± SD of 8 samples in arbitrary unit) while it was 
21.2 ± 1.9 under control conditions. Effects of 1–10 µM ARA were summarized in Fig. 4B. 
Significant augmentation of FluoZin-3 fluorescence was observed in the cases of 3–10 µM 
ARA (Fig. 4B). 
(Figure 4 near here) 
ARA-induced changes of intracellular Zn2+ levels in the presence of Zn2+ chelators and ZnCl2 
     The removal of external Zn2+ by 10 µM DTPA, a chelator of external Zn2+, reduced the 
control level of FluoZin-3 fluorescence (Fig. 5A). Even in the presence of DTPA, 10 µM ARA 
significantly increased the intensity of FluoZin-3 fluorescence from 10.0 ± 2.7 (control mean 
value ± SD of 10 samples in arbitrary unit) to 29.3 ± 5.1 (Fig. 5A). ARA at 10 µM increased the 
fluorescence intensity, in the absence of DTPA, from 13.2 ± 2.4 to 50.6 ± 5.2. Thus, the 
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removal of external Zn2+ by DTPA attenuated the ARA-induced augmentation of FluoZin-3 
fluorescence intensity. TPEN, a chelator of intracellular Zn2+, at 10 µM completely diminished 
the FluoZin-3 fluorescence (Fig. 5A). The addition of 3 µM ZnCl2 elevated the control level of 
FluoZin-3 fluorescence (Fig. 5B). The application of ARA increased the mean FluoZin-3 
fluorescence intensity from 51.1 ± 12.3 to 964.1 ± 523.1 in the presence of 3 µM ZnCl2 (Fig. 
5B).  
(Figure 5 near here) 
Effect of ARA on cellular content of nonprotein thiols 
     ARA increased the intensity of FluoZin-3 fluorescence in the presence of DTPA (Fig. 
5A), indicating the intracellular release of Zn2+. Intracellular Zn2+ forms a complex with the 
thiol group of proteins and nonproteins (Jacob et al., 1998). Modification from a thiol to 
disulfide, by oxidative stress, releases Zn2+ from the proteins and nonproteins (Maret, 1994). 
Therefore, to determine if ARA reduces the cellular content of nonprotein thiols, the change in 
the intensity of 5-CMF fluorescence by ARA was examined. Incubation with 3 µM ARA for 1 h 
significantly increased the intensity of 5-CMF fluorescence from 90.1 ± 9.3 (control level of 8 
samples in arbitrary unit) to 127.4 ± 6.5, while a significant decrease to 61.9 ± 13.9 was 
observed in the case of 10 µM ARA (Fig. 6). The application of 10 µM TPEN decreased the 
intensity of 5-CMF fluorescence under control conditions. In the presence of TPEN, 3 µM ARA 
slightly increased the intensity of 5-CMF fluorescence from 81.2 ± 4.9 (control level in arbitrary 
unit) to 90.1 ± 13.1 (Fig. 6). This change was not statistically significant. The significant 
decrease by 10 µM ARA was also observed in the presence of TPEN. Thus, the small increase 
in intracellular Zn2+ level by 3 µM ARA is supposed to increase cellular content of nonprotein 
thiols as described in the case of ZnCl2 (Kinazaki et al., 2011). 
(Figure 6 near here) 
 
Discussion 
 
     Cytotoxic actions of ARA have been reported in the papers by Pompéia et al. (2002, 
2003), Prasad et al. (2010), and Åhs et al. (2011), suggesting the involvement of oxidative stress 
and intracellular Ca2+. In the present study, the Zn2+-related cytotoxicity of ARA was revealed 
as follows. The addition of 10 µM ZnCl2 to the cell suspension increased cell lethality induced 
by 10 µM ARA, and the removal of Zn2+ by the Zn2+ chelators, 10 µM DTPA and 10 µM TPEN, 
attenuated the ARA-induced increase in cell lethality (Fig. 2). Thus, Zn2+ is supposed to be 
-8- 
partly involved in ARA cytotoxicity. ARA at 3–10 µM augmented the intensity of FluoZin-3 
fluorescence in a concentration-dependent manner, indicated by the ARA-induced increase of 
intracellular Zn2+ levels (Fig. 4). Zn2+ chelators attenuated the ARA-induced augmentation of 
FluoZin-3 fluorescence while ARA significantly increased the intensity of FluoZin-3 
fluorescence in the presence of 3 µM ZnCl2 (Fig. 5), suggesting the involvement of external 
Zn2+. Zn2+ is necessary for the development and function of lymphocytes (Shankar and Prasad, 
1998; Haase and Rink, 2014). Therefore, the excessive increase in intracellular Zn2+ levels by 
ARA may disturb cellular physiological functions that are related to Zn2+. Furthermore, in rat 
thymic lymphocytes, Zn2+ exerts cytotoxic action under oxidative stress induced by hydrogen 
peroxide (Matsui et al., 2010). Previous studies on ARA cytotoxicity reveal the involvement of 
oxidative stress (Pompéia et al., 2003; Prasad et al., 2010; Åhs et al, 2011). If ARA induces 
oxidative stress, the cellular content of nonprotein thiols would decrease. Nonprotein thiols such 
as metallothioneins are required to maintain the intracellular homeostasis of Zn2+ (Thirumoorthy 
et al., 2011). Therefore, a reduced ability to maintain Zn2+ homeostasis and increased influx of 
Zn2+ can induce an excessive increase in intracellular Zn2+ levels. Cellular Zn2+ dyshomeostasis 
is linked to a number of human pathologies (Rink and Gabriel, 2000; Prasad, 2013). In the 
present study, thymocytes were used as an experimental model. They are premature T 
lymphocytes derived from bone marrow hematopoietic progenitor cells that reach the thymus 
via circulation. A disrupted zinc homeostasis affects lymphocytes, leading to impaired 
formation, activation, and maturation (Maares and Haase, 2016). Thus, the simultaneous and 
continuous administration of zinc and ARA may disturb thymus-dependent 
T-lymphocyte-mediated immune responses. 
     Supplementary zinc is recommended in many clinical cases including diseases attributed 
to aging (Prasad, 2013; Roohani et al., 2013). ARA is thought to prevent and/or improve 
age-related decline in brain and cardiovascular system function (Kiso, 2011; Bell et al., 2014). 
Therefore, both zinc and ARA are occasionally used as a supplement by elderly persons. As 
shown in Fig. 5, ARA significantly increased intracellular Zn2+ levels in the presence of ZnCl2. 
If one takes zinc and ARA simultaneously, an unpredicted increase in intracellular Zn2+ levels 
might occur, resulting in harmful physical or mental effects. 
     This may be also the case in infants. It was reported that in very preterm infants, feeding 
of ARA-supplemented human milk in the early neonatal period, was associated with better 
recognition, memory, and higher problem-solving scores at 6 months (Henriksen et al., 2008). 
Supplementation with zinc maintained normative developmental trajectories, for selected 
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measures of attention, during the first 18 months of life (Colombo et al., 2014). Therefore, the 
possibility that some infants simultaneously take zinc and ARA cannot be ruled out. 
     The plasma concentration of ARA in humans was reported to be 1143 ± 468 ng/mL 
(Shinde et al., 2012). Calculated molar concentration is 3.7 ± 1.5 µM. Sánchez et al. (2009) 
reported the relationship between zinc intake and plasma zinc concentration in adult humans. In 
the mean zinc intake of 12.2 ± 7.1 mg/day for males and 9.0 ± 4.4 mg/day for females, mean 
plasma zinc concentrations were 17.4 ± 6.6 µM and 16.3 ± 6.2 µM, respectively. Therefore, the 
concentrations of ARA and ZnCl2 in this in vitro study may be plausible. However, it is noted 
that the plasma zinc concentration is not equal to Zn2+ concentration because Zn2+ is bound to 
thiols of proteins and nonproteins under the in vivo conditions. The caution is required to 
extrapolate this in vitro results to humans. 
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Figure legends 
 
Figure 1. Changes in the population of cells exhibiting propidium fluorescence after treatment 
with unsaturated fatty acids. (A) Cytogram of ARA-induced change (ordinate: forward scatter, 
abscissa: propidium fluorescence). Effect was examined 1 h after the start of the application of 
10 µM ARA. Each cytogram was constructed with 2500 cells. Dotted line indicates the 
population of cells exhibiting propidium fluorescence. (B) Concentration-dependent changes in 
the population of cells exhibiting propidium fluorescence after treatment with unsaturated fatty 
acids. Column and bar respectively indicate the mean population and standard deviation of the 
8–42 samples. Asterisks (**) show significant change (P < 0.01) between control group 
(CONTROL) and test group. 
 
Figure 2. Effects of ZnCl2 (A) and Zn2+ chelators (B) on the ARA-induced change in the 
population of cells exhibiting propidium fluorescence. Column and bar respectively indicate 
mean population and standard deviation of the 8–42 samples. Asterisks (**) show significant 
change (P < 0.01) between control group (CONTROL) and test group. Symbols (##) indicate 
significant changes (P < 0.01) between the groups indicated with arrows. 
 
Figure 3. Effects of cyclooxygenase inhibitors on ARA-induced change in the population of 
cells exhibiting propidium fluorescence. Column and bar respectively indicate the mean 
population and standard deviation of the 8–42 samples. Asterisks (**) show significant change 
(P < 0.01) between control group (CONTROL) and test group. Symbols (##) indicate 
significant changes (P < 0.01) between the groups indicated with arrows. 
 
Figure 4. Change in intensity of FluoZin-3 fluorescence by ARA. (A) ARA-induced shift of the 
FluoZin-3 fluorescence histogram. Each histogram was constructed with 2500 cells. (B) 
Concentration-dependent change in the intensity of FluoZin-3 fluorescence by ARA. Column 
and bar respectively indicate the mean intensity and standard deviation of 8 samples. Asterisks 
(**) show significant change (P < 0.01) between control group (CONTROL) and test group.  
 
Figure 5. Effects of Zn2+ chelators (A) and ZnCl2 (B) on ARA-induced change in the intensity 
of FluoZin-3 fluorescence. Column and bar respectively indicate the mean intensity and 
standard deviation of 8 samples. Asterisks (**) show significant change (P < 0.01) between 
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control group (CONTROL) and test group. Symbols (##) indicate significant changes (P < 0.01) 
between the groups indicated with arrows. 
 
Figure 6. Changes in intensity of 5-CMF fluorescence by ARA in the absence and presence of 
TPEN. Column and bar respectively indicate the mean intensity and standard deviation of 8 
samples. Asterisks (**) show significant change (P < 0.01) between control group (CONTROL) 
and test group. Symbols (##) indicate significant changes (P < 0.01) between the groups 
indicated with arrows. 
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